WallStreetZenWallStreetZen

NASDAQ: VKTX
Viking Therapeutics Inc Stock Ownership - Who owns Viking Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Viking Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian LianPresident CEO2025-10-2838,989$35.01
$1.36MSell
Greg ZanteChief Financial Officer2025-10-286,185$35.00
$216.48kSell
Marianna ManciniChief Operating Officer2025-10-286,185$35.00
$216.49kSell
Charles A. Rowland Jr.Director2025-10-2722,000$5.80
$127.60kBuy
Charles A. Rowland Jr.Director2025-10-2760,000$35.57
$2.13MSell
Charles A. Rowland Jr.Director2025-10-2722,000$4.88
$107.36kBuy
Charles A. Rowland Jr.Director2025-10-2716,000$4.48
$71.68kBuy
Brian LianPresident CEO2025-07-0326,889$27.80
$747.62kSell
Marianna ManciniChief Operating Officer2025-07-034,266$27.77
$118.47kSell
Greg ZanteChief Financial Officer2025-07-034,266$27.76
$118.43kSell

1 of 2

VKTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VKTX insiders and whales buy or sell their stock.

VKTX Shareholders

What type of owners hold Viking Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc8.85%9,999,107$353.97MInstitution
Ligand Pharmaceuticals Inc5.15%5,819,383$206.01MInsider
Fmr LLC5.12%5,790,051$204.97MInstitution
Blackrock Inc4.95%5,596,166$198.10MInstitution
State Street Corp3.99%4,513,832$159.79MInstitution
Morgan Stanley3.30%3,729,117$132.01MInstitution
Jpmorgan Chase Co2.28%2,577,087$91.23MInstitution
Brian Lian2.14%2,419,109$85.64MInsider
Susquehanna International Group LLP1.86%2,099,564$74.32MInstitution
Ameriprise Financial Inc1.85%2,092,840$74.09MInstitution

1 of 3

VKTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VKTX63.02%8.97%Net SellingNet Selling
MIRM52.35%47.65%Net SellingNet Buying
NAMS74.81%25.19%Net Selling
LEGN22.65%0.00%
GPCR31.11%11.89%Net Selling
View Top Biotech Stocks

Viking Therapeutics Stock Ownership FAQ

Who owns Viking Therapeutics?

Viking Therapeutics (NASDAQ: VKTX) is owned by 63.02% institutional shareholders, 8.97% Viking Therapeutics insiders, and 28.02% retail investors. Ligand Pharmaceuticals Inc is the largest individual Viking Therapeutics shareholder, owning 5.82M shares representing 5.15% of the company. Ligand Pharmaceuticals Inc's Viking Therapeutics shares are currently valued at $211.88M.

If you're new to stock investing, here's how to buy Viking Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.